PEAK trial first ever study to demonstrate statistical significance over an active comparator in GIST patients, with bezuclastinib plus ...
The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...
Achieve Life Sciences (ACHV) announced several milestones in its ORCA-OL long-term safety trial supporting the New Drug Application, NDA, review process of cytisinicline for smoking cessation. 120-Day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback